Skip to main content
Log in

Tenecteplase to treat pulmonary embolism in the emergency department

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Tenecteplase, a mutant form of alteplase, possesses pharmacological properties that might favor its use for emergent fibrinolysis of acute pulmonary embolism. Contemporaneous search of the World’s literature reveals 14 humans with acute pulmonary embolism treated with tenecteplase. Here, we summarize those cases and report the presentation features, dosing details and outcomes of eight additional patients with acute pulmonary embolism treated with tenecteplase in an academic emergency department. None of our eight patients had a significant hemorrhagic event after tenecteplase, and the outcomes of all eight appear to be acceptable. Taken together, we submit that the present case report and prior case reports are sufficient to comprise a phase I study of the safety and efficacy of tenecteplase to treat acute pulmonary embolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dunn CJ, Goa KL (2001) Tenecteplase: a review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarction. [Review] [68 refs]. Am J Cardiovas Drugs 1(1):51–66

    Article  CAS  Google Scholar 

  2. Tanswell P, Modi N, Combs D et al (2002) Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy of acute myocardial infarction. [Review] [64 refs]. Clinical Pharmacokinetics 41(15):1229–1245

    Article  PubMed  CAS  Google Scholar 

  3. Goldhaber SZ, Feldstein ML, Sors H (1994) Two trials of reduced bolus alteplase in the treatment of pulmonary embolism. An overview. Chest 106:725–726

    PubMed  CAS  Google Scholar 

  4. Goldhaber SZ, Agnelli G, Levine MN (1994) Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis: an international multicenter randomized trial. Chest 106:718–724

    PubMed  CAS  Google Scholar 

  5. Goldhaber SZ, Haire WD, Feldstein ML et al (1993) Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet 341:507–511

    Article  PubMed  CAS  Google Scholar 

  6. Konstantinides S, Tiede N, Geibel A et al (1998) Comparison of alteplase versus heparin for resolution of major pulmonary emoblism. Am J Cardiol 82(8):966–970

    Article  PubMed  CAS  Google Scholar 

  7. Konstantinides S, Geibel A, Heusel G et al (2002) Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. The New England J Med 347(15):1143–1150

    Article  CAS  Google Scholar 

  8. Thabut G, Logeart D (2005) Thrombolysis for pulmonary embolism in patients with right ventricular dysfunction: con. [comment]. [Review] [39 refs]. Arch Int Med 165(19):2200–2203

    Article  Google Scholar 

  9. Wan S, Quinlan DJ, Agnelli G, et al (2004) Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials. [see comment]. Circulation 110(6):744–749

    Article  PubMed  CAS  Google Scholar 

  10. Mascitelli L, Pezzetta F (2003) Thrombolysis in the treatment of submassive pulmonary embolism. [comment]. Arch Int Med 163(10):1238

    Article  Google Scholar 

  11. Thabut G, Thabut D, Myers RP et al (2002) Thrombolytic therapy of pulmonary embolism: a meta-analysis. J Am College Cardiol 40(9):1660–1667

    Article  CAS  Google Scholar 

  12. Sze DY, Carey MBL, Razavi MK (2001) Treatment of massive pulmonary embolus with catheter-directed tenecteplase. J Vasc Interv Radiol 12(12):1456–1457

    PubMed  CAS  Google Scholar 

  13. Caldicott D, Parasivam S, Harding J et al (2002) Tenecteplase for massive pulmonary embolus. Resuscitation 55(2):211–213

    Article  PubMed  Google Scholar 

  14. Lapanun W, Walters DL, McCarthy J et al (2003) Major pulmonary embolism and shock. Persistent hypotension after thrombolysis treated with improvised mechanical fragmentation of thrombus. Med J Aust 179(9):495–496

    PubMed  Google Scholar 

  15. Clement D, Loyant R, Labet T (2004) Tenecteplase and massive pulmonary embolus. Ann Fr Anesth Reanim 23(4):440–441

    Article  PubMed  CAS  Google Scholar 

  16. Livaditis IG, Paraschos M, Dimopoulos K (2004) Massive pulmonary embolism with ST elevation in leads V1–V3 and successful thrombolysis with tenecteplase. Heart (British Cardiac Society) 90(7):e41

    CAS  Google Scholar 

  17. Allocca G, Dall’Aglio V, Nicolosi GL (2005) [Tenecteplase for massive pulmonary embolism in a 92-year-old man]. Ital Heart J Suppl 6(6):390–393

    PubMed  Google Scholar 

  18. Melzer C, Richter C, Rogalla P et al (2004) Tenecteplase for the treatment of massive and submassive pulmonary embolism. J Thromb Thrombolysis 18(1):47–50

    Article  PubMed  CAS  Google Scholar 

  19. Medford AR, Maskell NA (2005) Images in resuscitation: bruising after thrombolysis for massive pulmonary embolism (PE). Resuscitation 65(2):131–132

    Article  PubMed  CAS  Google Scholar 

  20. Abdulla W, Netter U (2005) Case report. Successful use of tenecteplase in massive pulmonary embolism with cardiopulmonary resuscitation immediately following tracheostomy. Acta Anaesthesiol Belg 56(2):179–182

    PubMed  CAS  Google Scholar 

  21. Isma’eel H, Taher A, Alam S et al (2006) Massive pulmonary embolism in a Lebanese patient doubly heterozygous for MTHFR and Factor V Leiden presenting with syncope and treated with tenecteplase. J Thromb Thrombol 21(2):179–184

    Article  Google Scholar 

  22. Connor A, Narendran P, Contractor H et al (2006) Radiological and electrocardiographic changes following thrombolysis for acute pulmonary embolism with haemodynamic compromise. Resuscitation 68(3):315–317

    Article  PubMed  Google Scholar 

  23. van Beek EJR, Charbonnier B, Meyer G et al (2000) Guidelines on diagnosis and management of acute pulmonary embolism. Eur Heart J 21(16):1301–1336

    Article  Google Scholar 

  24. Kline JA, Hernandez J, Rose G et al (2006) Surrogate markers for adverse outcomes in normotensive patients with pulmonary embolism. Crit Care Med 34:2773–2180

    Article  PubMed  Google Scholar 

  25. Cannon CP, Gibson CM, McCabe CH et al (1998) TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. Circulation 98(25):2805–2814

    PubMed  CAS  Google Scholar 

  26. Van de WF (1999) Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Assessment of the Safety and Efficacy of a New Thrombolytic Investigators. Lancet 354:716–722

    Article  Google Scholar 

  27. Assessment of the Safety and Eficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators (2001) Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 358(9282):605–613

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey A. Kline.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kline, J.A., Hernandez-Nino, J. & Jones, A.E. Tenecteplase to treat pulmonary embolism in the emergency department. J Thromb Thrombolysis 23, 101–105 (2007). https://doi.org/10.1007/s11239-006-9018-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-006-9018-3

Keywords

Navigation